SJP-0132

· Senju Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SJP-0132, covering 2023-04-20 to 2023-04-20. Get the full timeline:

Most recent: Clinical Trial Update: Safety, PK and Efficacy Study of SJP-0132 in Subjects With Dry Eye Disease [Phase 1, Phase 2]